Genome & Company Market Cap

Genome & Company has a market cap or net worth of 83.62 billion as of June 27, 2025. Its market cap has decreased by -39.54% in one year.

Market Cap

83.62B

Enterprise Value

89.61B

Revenue

29.84B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,675.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 83.62B, an increase of 16.34%. That is a compound annual growth rate of 2.36%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	83.62B	-1.86%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	1,048.46B	224.28%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	401.04T
SK hynix	197.44T
Samsung Biologics	71.46T
LG Energy Solution	69.73T
Hyundai Motor Company	47.37T
NAVER	42.22T
Doosan Enerbility	42.14T
Hanwha Aerospace	40.39T

Market Cap Rankings